6,11-Dioxa-2,15,20-triazadocosanedioic acid,21-[[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]methyl]-16,19-dioxo-, 1-(1,1-dimethylethyl) ester, (S)- (139729-49-0)

Identification
Name:	6,11-Dioxa-2,15,20-triazadocosanedioic acid,21-[[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]methyl]-16,19-dioxo-, 1-(1,1-dimethylethyl) ester, (S)-
CAS:	139729-49-0
Molecular Formula:	C₃₄H₄₆I₃N₃O₁₀
Molecular Structure:
Properties
Safety Data

Other Product

6,11,18-Trioxa-2,15,21-triazatricosanedioic acid,22-[[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]methyl]-16,20-dioxo-, 1-(1,1-dimethylethyl) ester, (S)-
1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
3,6,9,12-Tetraoxa-15-azaheptadecan-17-oic acid,1-amino-16-[[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]methyl]-14-oxo-, (S)-, mono(trifluoroacetate) (salt)
1/C17H16N2O3/c1-9(20)12-8-14-15-11(6-7-19(14)17(22)16(12)21)10-4-2-3-5-13(10)18-15/h2-5,8-9,18,20-21H,6-7H2,1H
1/C20H20N2/c1-4-10-16(11-5-1)18-19(17-12-6-2-7-13-17)22-20(21-18)14-8-3-9-15-20/h1-2,4-7,10-13H,3,8-9,14-15H
1/C18H30O4/c1-4-5-6-7-15(19)13-16(20)10-8-14-9-11-17(21-2)18(12-14)22-3/h9,11-12,15-16,19-20H,4-8,10,13H2,1-3H3/t15-,16-/m0/s
1/C14H13N7O/c1-8-12(21-14(17)18-19-20-21)11(9-5-3-2-4-6-9)10(7-15)13(16)22-8/h2-6,11H,16H2,1H3,(H2,17,18,20
1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H
1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C18H32O3/c1-2-3-4-5-6-7-8-11-14-17(19)15-12-9-10-13-16-18(20)21/h11,14H,2-10,12-13,15-16H2,1H3,(H,20,21)/b14-11
6,11,24,29-Tetraoxa-2,15,20,33,38-pentaazatetracontanedioic acid,39-[[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]methyl]-16,19,34,37-tetraoxo-, 1-(1,1-dimethylethyl) ester, (S)-
1/C19H24N2O2/c1-12(2)14-8-6-9-15(13(3)4)17(14)21-19(22)18-16(23-5)10-7-11-20-18/h6-13H,1-5H3,(H,21,22
1/C16H14ClNO3/c1-10-6-12(17)7-11(15(10)19)8-18-9-21-16(20)13-4-2-3-5-14(13)18/h2-7,19H,8-9H2,1H
1/C23H22N2O2/c26-23(27-22-15-25-11-7-17(22)8-12-25)21-14-18(13-16-5-9-24-10-6-16)19-3-1-2-4-20(19)21/h1-6,9-10,13-14,17,22H,7-8,11-12,15H2/b18-13
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
1/C16H15FN2O3S/c1-23(21,22)19-14-5-3-2-4-13(14)18-16(20)10-15(19)11-6-8-12(17)9-7-11/h2-9,15H,10H2,1H3,(H,18,20